Related references
Note: Only part of the references are listed.Overview of the 2022 WHO Classification of Pituitary Tumors
Sylvia L. Asa et al.
ENDOCRINE PATHOLOGY (2022)
Epigenomic and somatic mutations of pituitary tumors with clinical and pathological correlations in 111 patients
Federica Guaraldi et al.
CLINICAL ENDOCRINOLOGY (2022)
Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients
Pia Burman et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2022)
Real-life clinical impact of a five-tiered classification of pituitary tumors
Nicolas Sahakian et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2022)
TP53 mutations in functional corticotroph tumors are linked to invasion and worse clinical outcome
Luis Gustavo Perez-Rivas et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2022)
USP8 and TP53 Drivers are Associated with CNV in a Corticotroph Adenoma Cohort Enriched for Aggressive Tumors
Andrew Uzilov et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Aggressive pituitary tumours and pituitary carcinomas
Gerald Raverot et al.
NATURE REVIEWS ENDOCRINOLOGY (2021)
Corticotroph Aggressive Pituitary Tumors and Carcinomas Frequently Harbor ATRX Mutations
Olivera Casar-Borota et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
A practical algorithm to predict postsurgical recurrence and progression of pituitary neuroendocrine tumours (PitNET)s
Federica Guaraldi et al.
CLINICAL ENDOCRINOLOGY (2020)
The epidemiology of aggressive pituitary tumors (and its challenges)
Olaf M. Dekkers et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2020)
Are aggressive pituitary tumors and carcinomas two sides of the same coin? Pathologists reply to clinician's questions
Jacqueline Trouillas et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2020)
Validation of a clinicopathological score for the prediction of post-surgical evolution of pituitary adenoma: retrospective analysis on 566 patients from a tertiary care centre
S. Asioli et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2019)
Both invasiveness and proliferation criteria predict recurrence of non-functioning pituitary macroadenomas after surgery: a retrospective analysis of a monocentric cohort of 120 patients
Julie Lelotte et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas
Gerald Raverot et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Aggressive pituitary tumours and carcinomas: two sides of the same coin?
Jacqueline Trouillas et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016
Ann McCormack et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
Risk of Recurrence in Pituitary Neuroendocrine Tumors: A Prospective Study Using a Five-Tiered Classification
Gerald Raverot et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up
Jacqueline Trouillas et al.
ACTA NEUROPATHOLOGICA (2013)
Aggressive and malignant prolactin pituitary tumors: pathological diagnosis and patient management
Ilyess Zemmoura et al.
PITUITARY (2013)